ZNF722P

Across TCGA pan-cancer cohorts, ZNF722P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ZNF722P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where ZNF722P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF722P is over-expressed in tumor.

BRCA, LIHC, and LUAD are the cancer types where ZNF722P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF722P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.059	.033	4	view →
LIHC	All	All	+0.171	.006	2	view →
LUAD	All	All	+0.101	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ZNF722P–BRCA

Open the BRCA breakdown →